They further demonstrated that pelvic PSMA PET/MR is better than whole-body PSMA PET/CT for detecting extensions of localized disease, and may be useful for initial evaluation of prostate cancer (20). This evidence concerns the gene FOLH1 and Familial prostate cancer.